We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy

This study is currently recruiting participants.
Verified July 2016 by Stanford University
Sponsor:
ClinicalTrials.gov Identifier:
NCT00349830
First Posted: July 10, 2006
Last Update Posted: July 12, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Stanford University
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: January 2022 (Final data collection date for primary outcome measure)